Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
MainStay Balanced B MBNBX
- NAV / 1-Day Return 30.16 / +0.24 %
- Total Assets 463.7 Mil
-
Adj. Expense Ratio
- Expense Ratio 2.080%
- Distribution Fee Level High
- Share Class Type —
- Category Moderate Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity High/Limited
- Status Closed
- TTM Yield 1.03%
- Turnover 313%
USD | NAV as of Mar 28, 2024 | 1-Day Return as of Mar 28, 2024, 10:04 PM GMT+0
Morningstar’s Analysis MBNBX
Will MBNBX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings —
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
United States Treasury Notes 4.25% | 6.47 | 29.4 Mil | Government |
United States Treasury Notes 4% | 5.07 | 23.0 Mil | Government |
iShares Intermediate Govt/Crdt Bd ETF | 4.23 | 19.2 Mil | — |
United States Treasury Notes 4% | 3.22 | 14.6 Mil | Government |
United States Treasury Notes 4% | 2.45 | 11.1 Mil | Government |
iShares Russell 1000 Value ETF | 2.19 | 9.9 Mil | — |
JPMorgan Chase & Co | 2.15 | 9.7 Mil | Financial Services |
Vanguard Russell 1000 Value ETF | 1.97 | 9.0 Mil | — |
Johnson & Johnson | 1.70 | 7.7 Mil | Healthcare |
Merck & Co Inc | 1.67 | 7.6 Mil | Healthcare |